mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |